ON
← Back to feed
Nobel prize in medicine goes to U..S, German scientists for brain research
CA🔬 ScienceCenter

Nobel prize in medicine goes to U..S, German scientists for brain research

The Nobel Prize in Medicine was awarded to three scientists from the United States and Germany for their groundbreaking work on light-gated ion channels and optogenetics. Their research has significantly advanced the understanding of neural circuits and opened new avenues for treating neurological disorders. The Nobel Assembly at Sweden's Karolinska Institute announced the selection based on their discoveries, which allow precise control of neurons using light. This innovation has potential applications in both basic neuroscience research and clinical treatments for conditions such as Parkinson's disease and blindness.

The 2026 Nobel Prize in Physiology or Medicine was awarded on Monday to three scientists, American Karl Deisseroth, German Peter Hegemann, and German Georg Nagel, for their groundbreaking work in developing optogenetics, a technique that allows researchers to control individual nerve cells in the brain using light. The Nobel Assembly at Sweden’s Karolinska Institute cited their discoveries concerning light-gated ion channels and optogenetics as the reason for the award. The three scientists will share a prize sum of 12 million Swedish kronor (approximately $1.2 million). The development of optogenetics began in the 1980s when Hegemann, a biophysicist at the Max Planck Institute of Biochemistry in Martinsried, Germany, studied how pond algae responded to sunlight. His research focused on the ability of algae to move upward or downward depending on the intensity of light, a process crucial for regulating photosynthesis. This investigation led to the identification of a class of proteins called channelrhodopsins, which enable algae to convert light into electrical signals. Hegemann identified the gene responsible for channelrhodopsin in algae, and Nagel later demonstrated its functionality by inserting the gene into frog egg cells. Their combined efforts revealed a protein capable of opening ion channels in response to light, creating an electrical impulse. This discovery laid the foundation for a revolutionary tool in neuroscience. In 2005, Deisseroth, along with Ed Boyden, a postdoctoral researcher at Stanford University, demonstrated how the channelrhodopsin gene could be integrated into the DNA of rat neurons. This allowed for the activation or deactivation of specific brain cells using light, marking the birth of optogenetics. The term "optogenetics" was coined in 2006. Optogenetics has since transformed the study of the brain, enabling researchers to map neural circuits with unprecedented precision. Scientists have used the technique to investigate how the brain processes information, regulates emotions, and controls behaviors such as learning and memory. The method has also been applied to understand and potentially treat various neurological and psychiatric disorders, including schizophrenia, Alzheimer’s disease, Parkinson’s disease, epilepsy, and addiction. In addition to its applications in neuroscience, optogenetics has been extended to other fields. Researchers are exploring ways to use light to activate cells for therapeutic purposes, such as restoring vision in individuals affected by retinitis pigmentosa, a genetic form of blindness. The technique holds promise for future treatments in areas such as cancer and diabetes. Deisseroth expressed surprise and excitement upon receiving the news, stating he was still awake when contacted by the Nobel Committee. He reflected on his journey into neuroscience, noting that encounters with patients who lacked effective treatments inspired him to seek answers about the brain’s complexity. His work has since contributed significantly to the field, offering new insights into the functioning of the nervous system. The Nobel Assembly emphasized the transformative impact of optogenetics, describing it as a tool that has shifted the understanding of the brain from a rudimentary map to a detailed and dynamic model. Experts noted that the technique has enabled researchers to explore previously inaccessible aspects of neural function, paving the way for further scientific and medical advancements. The announcement of the Nobel Prize in Medicine marks the beginning of Nobel Week, with upcoming awards in Physics, Chemistry, Literature, and the Peace Prize scheduled for the following days. The Economics Prize will be announced on October 12. The recognition of Deisseroth, Hegemann, and Nagel underscores the significance of interdisciplinary research and highlights the potential of innovative scientific approaches to address complex biological questions.

How this report was made. Objective News wrote this report from 2 source articles, using AI-assisted synthesis under our methodology. It is our own text, not a copy of any single outlet. Read our methodology.

Responsible editor: Matej BašaSpotted an error? Report it

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

2 reports

Global News logoGlobal NewsIndependentCenterFactual: no official source document/info detectedObjective 90
Nobel prize in medicine goes to U..S, German scientists for brain research

The Nobel Prize in Medicine was awarded to three scientists from the United States and Germany for their groundbreaking work on light-gated ion channels and optogenetics. Their research has significantly advanced the understanding of neural circuits and opened new avenues for treating neurological disorders. The Nobel Assembly at Sweden's Karolinska Institute announced the selection based on their discoveries, which allow precise control of neurons using light. This innovation has potential applications in both basic neuroscience research and clinical treatments for conditions such as Parkinson's disease and blindness.

Bias read (Center): The article reports on a scientific achievement without any political commentary, framing, or bias. It focuses solely on the scientific contributions and does not take a stance on political issues.

Why factuality: no official source document/info detected

Why objectivity (90): The article presents the information in a neutral tone, focusing on the scientific achievement without expressing personal opinion or bias. It uses objective language and does not favor any particular perspective.

The Globe and Mail logoThe Globe and MailIndependent🔒CenterFactual: no official source document/info detectedObjective 90
Nobel prize in medicine awarded to researchers who learned how to light up the brain

The Nobel Prize in Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their pioneering work in developing optogenetics, a scientific field that enables precise control of neurons using light. Their research has significantly advanced neuroscience by allowing scientists to activate or deactivate specific brain cells with high precision. This breakthrough has opened new avenues for understanding neurological disorders and developing potential treatments. The award highlights the growing importance of interdisciplinary approaches in medical science.

Bias read (Center): The article presents a factual report on a scientific achievement without overt ideological framing. It focuses on the technical contributions of the researchers and does not take a stance on the broader implications of their work beyond acknowledging its significance in neuroscience.

Why factuality: no official source document/info detected

Why objectivity (90): The article maintains an objective tone, presenting the information without emotional language or editorializing. It focuses solely on the scientific achievement and the recognition received by the researchers.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories